Tapinarof cream shown to be beneficial in atopic dermatitis patients as young as 2 years old: ADORING 2 trial Dr. Kamal Kant Kohli17 March 2023 7:45 PM ISTUSA: Topical VTAMA (tapinarof) cream was shown to be safe and effective in pediatric subjects down to 2 years old and adult subjects with atopic...
Goselkumab therapy beneficial for patients with moderate to severe plaque psoriasis Aditi31 Jan 2023 9:45 AM ISTUSA: A research report of a real-world study published in Dermatology and Therapy has concluded that patients with moderate-to-severe plaque...
Sponsor should submit rescue management plan: CDSCO Panel Tells Sun Pharma Over Psoriasis Drug Tildrakizumab Susmita Roy18 Jan 2023 6:00 PM ISTNew Delhi: Granting the permission to conduct the proposed study of Tildrakizumab 100mg/ml, the Subject Expert Committee (SEC) functional under the...
Researchers develop promising drug delivery method that could replace injections with pills Dr. Kamal Kant Kohli9 Jan 2023 7:30 PM ISTFor some chronic conditions such as rheumatoid arthritis, treatment often involves lifelong injections. New delivery strategies that combine efficacy...
Mirikizumab efficacy to placebo for treating moderate-to-severe plaque psoriasis Medha Baranwal3 Jan 2023 8:00 PM ISTUSA: Interleukin (IL)-23 and IL-17 are known to play critical roles in the development of psoriatic disease, so therapies targeting these cytokines...
Palmoplantar Plaque Psoriasis associated with Diabetes, Hypertension, Obesity, and Metabolic Syndrome- IDOJ Study Dr Manoj Kumar Nayak2 Jan 2023 9:45 AM ISTPalmoplantar Plaque Psoriasis associated with Diabetes, Hypertension, Obesity, and Metabolic Syndrome- IDOJ Study Psoriasis is a T cell‑mediated...
Secukinumab Dose Tapering ensures increased effectiveness of plaque psoriasis treatment Dr. Kamal Kant Kohli21 Oct 2022 7:30 PM ISTCHINA: According to a research study published in the journal Dermatologic Therapy, tapering off secukinumab dosages for individuals with plaque...
Biocon Biologics collaborates with Yoshindo to commercialize bUstekinumab, bDenosumab in Japan Ruchika Sharma17 Oct 2022 2:30 PM ISTDenosumab, a biosimilar referencing Prolia, is a monoclonal antibody for the treatment of osteoporosis.
Tildrakizumab therapy proves beneficial for Plaque Psoriasis Dr. Kamal Kant Kohli3 Oct 2022 8:00 PM ISTITALY: Tildrakizumab was found to be beneficial for up to 36 weeks in treating moderate-to-severe plaque psoriasis, according to a new study published...
Roflumilast cream effective for treating plaque psoriasis: JAMA Dr. Kamal Kant Kohli26 Sept 2022 7:30 PM ISTUSA: According to a study published in JAMA Network, roflumilast cream was effective in treating plaque psoriasis in patients after 8 weeks of...
Lupin gets Health Canada nod for plaque psoriasis treatment Rymti Ruchika Sharma13 Sept 2022 2:19 PM ISTMumbai: Global pharma major, Lupin Limited, announced today that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in...
Bristol Myers Squibb bags USFDA approval for plaque psoriasis oral treatment Sotyktu Ruchika Sharma12 Sept 2022 1:29 PM ISTPsoriasis is a widely prevalent, chronic, systemic immune-mediated disease.
